new startup is hoping to cash in on a disturbing trend that has
been growing in popularity among the ultra-rich. It is a treatment
in which blood from young people is injected into the veins of
it has been reported that
this practice has been popular underground in Silicon Valley for
years now, this is the first company to officially offer the
service to the public. Stanford Medical graduate Jesse Karmazin is
the founder of Ambrosia Medical, which plans to open its first
clinic in New York City in the next few months.
was involved in the first clinical trials in the US that tested
the effects of this treatment.
study has not yet been made public, but Karmazin told Business
Insider the results were “really positive.”
blood transfusions are already approved by the FDA, Ambrosia has
had very few regulatory hurdles in opening their business. As
Business Insider reports:
trial, which involved giving patients 1.5 liters of plasma from
a donor between the ages of 16 and 25 over two days, was
conducted with physician David Wright, who owns a private
intravenous-therapy center in Monterey, California. Before
and after the infusions, participants’ blood was tested for a
handful of biomarkers, or measurable biological substances and
processes that are thought to provide a snapshot of health and
the week since the company launched their website, they have
already received over 100 calls from people requesting
many people were reaching out to us that we wanted to make a
simple way for them to be added to the list,” David Cavalier,
Ambrosia’s chief operating officer said.
the trials, patients paid $8,000 to be involved and receive the
treatment, but the company has clarified that the price the public
sees may be much different, even higher, than what the trial
“The trial was an
investigational study. We saw some interesting things and we do
plan to publish that data. And we want to begin to open clinics
where the treatment will be made available,” Cavalier said.
know it sounds too outrageous to be true, but these outlandish
practices have been commonplace among aristocrats in various
different cultures throughout history. Before going further, it is
important to point out that two consenting adults involved in a
voluntary agreement such as this is entirely acceptable. However,
some of these “donors” are only 16 years old. The age to donate
blood legally in New York is 17. Donating under 17 requires written
consent from the parent.
more, there are implications that tie this to a very dark side of
human history. In most modern cultures, mass murder and human
sacrifice still takes place out in the open under the cover of
warfare, while many argue that cannibalism also still takes place
but behind closed doors.
is only in the past few hundred years that the practice of
cannibalism among royals has not been publicized. In Europe,
around the time of the American Revolution “corpse medicine” was
very popular among the ruling class, Charles II even
brewed his own.
Richard Sugg of Durham University has conducted
extensive research into the practice of
corpse medicine among the royalty.
“The human body has been widely
used as a therapeutic agent with the most popular treatments
involving flesh, bone or blood. Cannibalism
was found not only in the New World, as often believed, but also
in Europe,” Sugg said.
“One thing we are rarely taught
at school yet is evidenced in literary and historic texts of the
time is this: James I refused corpse medicine; Charles II made
his own corpse medicine; and Charles I was made into corpse
medicine. Along with Charles II, eminent
users or prescribers included Francis I, Elizabeth I’s surgeon
John Banister, Elizabeth Grey, Countess of Kent, Robert Boyle,
Thomas Willis, William III, and Queen Mary,” he
year, journalist Jeff Bercovici said that Silicon Valley
aristocrats like Peter Thiel were receiving similar transfusions.
“There are widespread rumors in
Silicon Valley, where life-extension science is a popular
obsession, that various wealthy individuals from the tech world
have already begun practicing parabiosis, spending tens of
thousands of dollars for the procedures and young-person-blood,
and repeating the exercise several times a year,” Bercovici
his article, Bercovici
also expressed concerns about a developing black market for young